Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.51 |
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.51 |
| ▸ | HTR2A | P28223 | 2/20 | 0.51 |
| ▸ | HTR1A | P08908 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | HTR7 | P34969 | 1/20 | 0.51 |
| ▸ | HTR2B | P41595 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5793704 | 1.00 | KDM4E (0.51) | KDM4EALOX15HSD17B10CYP3A4KMT2A | |
| Hydrochloric Acid SCHEMBL27466244 | 0.98 | KDM4E (0.50) | KDM4EALOX15HSD17B10CYP3A4KMT2A | |
| Hydrochloric Acid SCHEMBL27466243 | 0.98 | KDM4E (0.50) | KDM4EALOX15HSD17B10CYP3A4KMT2A | |
| SCHEMBL9513810 | 0.85 | ALOX15 (0.51) | KDM4EALOX15HSD17B10CYP3A4KMT2A | |
| SCHEMBL7773942 | 0.85 | IDO1 (0.50) | KDM4EALOX15HSD17B10CYP3A4KMT2A | |
| SCHEMBL27535126 | 0.85 | ALOX15 (0.51) | KDM4EALOX15HSD17B10CYP3A4KMT2A | |
| SCHEMBL6584398 | 0.85 | ALOX15 (0.51) | KDM4EALOX15HSD17B10CYP3A4KMT2A | |
| SCHEMBL1312888 | 0.85 | GRB2 (0.54) | KDM4EALOX15HSD17B10CYP3A4KMT2A | |
| SCHEMBL1312890 | 0.85 | GRB2 (0.54) | KDM4EALOX15HSD17B10CYP3A4KMT2A | |
| SCHEMBL24803738 | 0.81 | HSD17B10 (0.42) | KDM4EALOX15HSD17B10CYP3A4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220160905-A1 | FLUORINATION METHOD | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-05-26 | — | — | US | disclosed |
| US-20220160905-A1 | FLUORINATION METHOD | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2022-05-26 | — | — | US | disclosed |
| WO-2006017619-A2 | RECEPTOR-BINDING CYCLIC PEPTIDES AND METHODS OF USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-02-16 | — | — | WO | disclosed |
| US-20060029544-A1 | Receptor-binding cyclic peptides and methods of use | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF TECHNOLOGY TRANSFER (US) | 2006-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220160905-A1 | FLUORINATION METHOD | AFF2, AFF1, AFF4 | KDM4E 2786/4885ALOX15 2261/4885HSD17B10 2347/4885 |
| US-20060029544-A1 | Receptor-binding cyclic peptides and methods of use | ITGB3, ITGB5, ITGA5 | KDM4E 3616/4885ALOX15 3927/4885HSD17B10 4773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.